[go: up one dir, main page]
More Web Proxy on the site http://driver.im/

PL3490533T3 - Sposób stabilizacji rozmiaru cząstek - Google Patents

Sposób stabilizacji rozmiaru cząstek

Info

Publication number
PL3490533T3
PL3490533T3 PL17751294T PL17751294T PL3490533T3 PL 3490533 T3 PL3490533 T3 PL 3490533T3 PL 17751294 T PL17751294 T PL 17751294T PL 17751294 T PL17751294 T PL 17751294T PL 3490533 T3 PL3490533 T3 PL 3490533T3
Authority
PL
Poland
Prior art keywords
particle size
stabilization process
size stabilization
particle
stabilization
Prior art date
Application number
PL17751294T
Other languages
English (en)
Inventor
Josep TERRADAS CAMINS
Josep María CARULLA OLIVER
Silvia DONNICI GARCÍA
David GÓMEZ LAMARCA
María José MARTÍNEZ VELÓN
Emma RECIO SOLER
Original Assignee
Inke, S.A.
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Inke, S.A. filed Critical Inke, S.A.
Publication of PL3490533T3 publication Critical patent/PL3490533T3/pl

Links

Classifications

    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61JCONTAINERS SPECIALLY ADAPTED FOR MEDICAL OR PHARMACEUTICAL PURPOSES; DEVICES OR METHODS SPECIALLY ADAPTED FOR BRINGING PHARMACEUTICAL PRODUCTS INTO PARTICULAR PHYSICAL OR ADMINISTERING FORMS; DEVICES FOR ADMINISTERING FOOD OR MEDICINES ORALLY; BABY COMFORTERS; DEVICES FOR RECEIVING SPITTLE
    • A61J3/00Devices or methods specially adapted for bringing pharmaceutical products into particular physical or administering forms
    • A61J3/02Devices or methods specially adapted for bringing pharmaceutical products into particular physical or administering forms into the form of powders
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00Medicinal preparations characterised by special physical form
    • A61K9/0012Galenical forms characterised by the site of application
    • A61K9/007Pulmonary tract; Aromatherapy
    • A61K9/0073Sprays or powders for inhalation; Aerolised or nebulised preparations generated by other means than thermal energy
    • A61K9/0075Sprays or powders for inhalation; Aerolised or nebulised preparations generated by other means than thermal energy for inhalation via a dry powder inhaler [DPI], e.g. comprising micronized drug mixed with lactose carrier particles
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00Medicinal preparations containing organic active ingredients
    • A61K31/33Heterocyclic compounds
    • A61K31/395Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
    • A61K31/40Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having five-membered rings with one nitrogen as the only ring hetero atom, e.g. sulpiride, succinimide, tolmetin, buflomedil
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00Medicinal preparations containing organic active ingredients
    • A61K31/33Heterocyclic compounds
    • A61K31/395Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
    • A61K31/40Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having five-membered rings with one nitrogen as the only ring hetero atom, e.g. sulpiride, succinimide, tolmetin, buflomedil
    • A61K31/4015Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having five-membered rings with one nitrogen as the only ring hetero atom, e.g. sulpiride, succinimide, tolmetin, buflomedil having oxo groups directly attached to the heterocyclic ring, e.g. piracetam, ethosuximide
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K45/00Medicinal preparations containing active ingredients not provided for in groups A61K31/00 - A61K41/00
    • A61K45/06Mixtures of active ingredients without chemical characterisation, e.g. antiphlogistics and cardiaca
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00Medicinal preparations characterised by special physical form
    • A61K9/14Particulate form, e.g. powders, Processes for size reducing of pure drugs or the resulting products, Pure drug nanoparticles
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P11/00Drugs for disorders of the respiratory system
    • A61P11/06Antiasthmatics

Landscapes

  • Health & Medical Sciences (AREA)
  • Animal Behavior & Ethology (AREA)
  • General Health & Medical Sciences (AREA)
  • Veterinary Medicine (AREA)
  • Public Health (AREA)
  • Chemical & Material Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Epidemiology (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Engineering & Computer Science (AREA)
  • Pulmonology (AREA)
  • Otolaryngology (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • General Chemical & Material Sciences (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Organic Chemistry (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Medicinal Preparation (AREA)
PL17751294T 2016-07-29 2017-07-25 Sposób stabilizacji rozmiaru cząstek PL3490533T3 (pl)

Applications Claiming Priority (3)

Application Number Priority Date Filing Date Title
EP16382374 2016-07-29
EP17751294.4A EP3490533B1 (en) 2016-07-29 2017-07-25 Particle size stabilization process
PCT/EP2017/068707 WO2018019803A1 (en) 2016-07-29 2017-07-25 Particle size stabilization process

Publications (1)

Publication Number Publication Date
PL3490533T3 true PL3490533T3 (pl) 2020-11-02

Family

ID=56842772

Family Applications (1)

Application Number Title Priority Date Filing Date
PL17751294T PL3490533T3 (pl) 2016-07-29 2017-07-25 Sposób stabilizacji rozmiaru cząstek

Country Status (7)

Country Link
US (1) US10888500B2 (pl)
EP (1) EP3490533B1 (pl)
AR (1) AR109186A1 (pl)
ES (1) ES2805434T3 (pl)
PL (1) PL3490533T3 (pl)
PT (1) PT3490533T (pl)
WO (1) WO2018019803A1 (pl)

Family Cites Families (8)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US2956062A (en) 1959-02-26 1960-10-11 Robins Co Inc A H Esters of amino alcohols
GB0409703D0 (en) 2004-04-30 2004-06-02 Vectura Ltd Pharmaceutical compositions
WO2009007666A1 (en) 2007-07-10 2009-01-15 Redcliffe Magtronics Ltd Automatic vehicle guidance protection system
CA2707594C (en) 2007-12-13 2015-08-18 Novartis Ag Process for preparing particulates of crystalline drug substance
EP2234595B1 (en) 2007-12-13 2012-11-28 Novartis AG Process for reducing the tendency of a glycopyyronium salt to aggegate during storage.
ES2712988T5 (es) 2013-03-15 2022-10-21 Pearl Therapeutics Inc Métodos y sistemas para acondicionamiento de materiales cristalinos en partículas
US9393202B2 (en) * 2013-04-26 2016-07-19 Chiesi Farmaceutici S.P.A Particle size reduction of an antimuscarinic compound
ES2700597T3 (es) 2014-12-24 2019-02-18 Lesvi Laboratorios Sl Proceso para la preparación de (3RS) -3 - [(2SR) - (2-ciclopentil-2-hidroxi-2-fenilacetil) oxi] -1,1-dimetilpirrolidinio

Also Published As

Publication number Publication date
PT3490533T (pt) 2020-07-21
US10888500B2 (en) 2021-01-12
EP3490533A1 (en) 2019-06-05
US20190175451A1 (en) 2019-06-13
WO2018019803A1 (en) 2018-02-01
EP3490533B1 (en) 2020-05-27
AR109186A1 (es) 2018-11-07
ES2805434T3 (es) 2021-02-12

Similar Documents

Publication Publication Date Title
HK1249994A1 (zh) 具有減小的粒度的電子汽化器
IL246989A0 (en) A controlled process to reduce particle size
PL3265271T3 (pl) Podajnik cząstek
GB201609546D0 (en) Process
IL255354B (en) Stable suspensions of nanomagnetic particles
GB201605121D0 (en) Process
GB201615268D0 (en) Process
PL3096866T3 (pl) Drobnoziarnisty węgiel aktywowany
GB201609873D0 (en) Process
GB201615270D0 (en) Process
GB201600290D0 (en) Process
GB201617500D0 (en) Process
GB201602646D0 (en) Process
GB201602584D0 (en) Process
GB201701573D0 (en) Virus-like particle
GB201600456D0 (en) Process
GB201600287D0 (en) Process
GB201617463D0 (en) Process
EP3356472C0 (en) PARTICLE SURFACE TREATMENT
GB201610852D0 (en) Process
PT3548452T (pt) Partícula de fertilizante
GB201411407D0 (en) Particle beam treatment
GB201613014D0 (en) Process
EP3414334C0 (en) PROCESS
GB201610338D0 (en) Process